CRLBF logo

CRLBF Cresco Labs Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$0.77
-0.03 (-3.38%)

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Domini…

Market Cap: $273.11Mwww.crescolabs.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 12Aug 12

Quote

Day Range
$0.75 – $0.81
52-Week Range
$0.59 – $2.30
Volume
$81.1K
Market Cap
$273.11M
50-Day Avg
$0.77
200-Day Avg
$0.97
Prev Close
$0.80
Open
$0.80

Valuation & Ratios

P/E Ratio
-3.15
EPS
$-0.40
P/B Ratio
1.23
P/S Ratio
0.63
Debt/Equity
1.72
Current Ratio
2.59
Dividend Yield
+0.0%
Gross Margin
+46.4%

Returns & Efficiency

Return on Equity
-40.5%
Return on Assets
-11.5%
FCF Yield
+9.2%
EV/EBITDA
5.85

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$667.33M$-137.78M$-0.39
2024$724.34M$-74.44M$-0.22
2023$770.88M$-175.52M$-0.54
2022$842.68M$-212.05M$-0.71
2021$821.68M$-319.60M$-1.22

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $-0.02 per share

2of 7 quarters beat consensus

Typical surprise -33.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$0.04 vs $-0.02beat
  • Fri, May 8$-0.04 vs $-0.03miss
  • Thu, Mar 5$-0.24 vs $-0.01miss
  • Wed, Nov 5$-0.05 vs $-0.03miss
  • Thu, Aug 7$-0.05 vs $-0.04miss
  • Fri, May 30$-0.04 vs $-0.03miss

Estimates and results for CRLBF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

CRLBFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsmarijuanastocks.com·3d ago·Neutral

    3 Marijuana Stocks For Investors To Consider What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US, what happens at the federal level has moved the needle the most, with the recent passing of legislation to reclassify cannabis to Schedule 3.

    View source ↗